Erik Amble

Erik founded NeoMed in 1997 and served as its Managing Partner until 2015. He will continue to manage NeoMed’s funds and is available to advise on certain investments for Omega Fund V. He has over 30 years’ experience of venture capital investing in Europe and the United States, the last 20 of which have been in the healthcare industry. Previously, Erik was Chairman of NeoMed AS, an investment advisory firm specialized in the healthcare industry, and President of Origo Ventures AS, a Norwegian private equity firm. Erik is a co-founder and former chairman of the Norwegian Venture Capital Association. Erik holds a Master’s degree of Science in Management from the Graduate School of Business, Stanford University, and a PhD in Organic Chemistry from the University of Oslo, Norway.